Anti-interleukin-5 therapy (mepolizumab) in life-threatening asthma attack: A case-based discussion

We report about a case of a compassionate off-label use of the anti-interleukin-5-agent mepolizumab in a ventilated patient with life-threatening asthma attack in eosinophilic asthma. The patient suffered from severe eosinophilic asthma and was transmitted to our hospital with an asthma attack and a...

Descripción completa

Detalles Bibliográficos
Autores principales: Tello, Khodr, Hoffmann, Andreas, Beutel, Björn, Greulich, Timm, Vogelmeier, Claus Franz, Richter, Manuel Jonas, Kuhnert, Stefan, Böselt, Tobias, Alter, Peter, Holland, Angelique, Idzko, Marco, Buhl, Roland, Koczulla, Andreas Rembert
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2019
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6715903/
https://www.ncbi.nlm.nih.gov/pubmed/31485410
http://dx.doi.org/10.1016/j.rmcr.2019.100927

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6715903/
https://www.ncbi.nlm.nih.gov/pubmed/31485410
http://dx.doi.org/10.1016/j.rmcr.2019.100927

Ejemplares similares